Emerald Health: Q2 ’19
Included in this report:
• Cannin Tools
• Market & Industry Update
• Fundamental Analysis (Emerald Health)
• Medical Research
• Cannabis Terminology
• Hemp Infographic
• Industry Terminology
About Emerald Health
Primary: Production and sales of cannabis in Canada. Later, broader markets, such as Europe. Emerald is science focused, is developing proprietary genetics, has PhD scientists and big-Pharma vets in senior management. Management is interested in the economic potential of CBD.
Secondary: Through the University of British Columbia, it is studying treatments of neurodegenerative and neuroinflammatory diseases, as well as metabolic and other diseases.
Search Cannabis and Hemp Stocks
- Trulieve: When to Buy or Sell this Cannabis Stock
- Cannin’s Top 5 Psychedelic Stocks for 2021
- How is Patagonia Creating a Domestic Supply Chain for Hemp Fiber?
- ScottsMiracle-Gro Announces Record Second Quarter Results
- Biden Proposes Plan to Pay Hemp Farmers for Carbon
- What States are Most Likely to Legalize Marijuana in 2021?
- South Dakota Supreme Court and Amendment A – What’s Next?
Cannabis Stock Watchlist
|Symbol||Last Price||% Change|
Search for Specific Hemp and Cannabis Stocks
From the Cannin Community
"Cannin sends specific instructions on how to make the trade. They continue to send profitable signals and I love their service. Thanks, Cannin!"